Delivery Order SPE2DB22D3301-SPE2DB23FZ4MD
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $367,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.4 mg/2 ml vials of glycopyrrolate. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to...
- The Defense Logistics Agency awarded a $720.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561738928 glycopyrrolate 0.2 mg/ml vials. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for five milliliter vials of the specified medication and has a period of performance from August 8 to August 9, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No...
- The Defense Logistics Agency awarded a $2,145.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561315916 glycopyrrolate 0.2 mg/ml vials. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance is from June 22, 2023 through June 23, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for pharmaceuticals and medical supplies to support military...
- The Defense Logistics Agency awarded a $274,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for glycopyrrolate injection 0.2 mg/ml vials. The single day contract has a period of performance of September 14-15, 2023 for product delivery from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the Defense Logistics Agency's requirement or whether this delivery order was placed against an existing Government-wide...
- The Defense Logistics Agency awarded a $91,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for glycopyrrolate injectable solution. The contract has a period of performance of one day, from June 20, 2023 through June 21, 2023. Performance will take place in Conshohocken, Pennsylvania. The Defense Logistics Agency supports Department of Defense procurement and supply chain management programs. No set aside designation or subcontractors were indicated. This delivery...
- The Defense Logistics Agency awarded a $720.50 delivery order to Amerisourcebergen Drug Corporation for 4561706107 GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 4-7, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the specified glycopyrrolate injectable product in support of DLA's...
- The Defense Logistics Agency awarded a $306,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for glycopyrrolate 0.4 mg/2 ml vials. The contract has a period of performance from August 18-21, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. The award is in support of the Defense Logistics Agency's medical supply needs and was issued under the agency's indefinite-delivery/indefinite-quantity pharmaceutical distribution vehicle....
- The Defense Logistics Agency Troop Support Medical awarded a $3,734.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561531690 Glycopyrrolate 4 mg/20 ml vials. The delivery order is for 20 ml vials of the medication to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance required from July 18-19, 2023. As a key medical supplier to the Department of Defense, the Defense Logistics Agency Troop Support Medical utilizes contracts...
- The Defense Logistics Agency awarded a $30,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561680467 glycopyrrolate 0.2 mg/ml vials. Under this contract, Amerisourcebergen will deliver 5 ml vials of the specified medication to a location in Conshohocken, Pennsylvania by August 3, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and stocks critical medical supplies, so this contract will...
- The Defense Logistics Agency Troop Support Medical awarded a $36,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 boxes containing 1 milligram tablets of glycopyrrolate. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 16, 2023 through August 17, 2023. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle, though details...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ4MDDelivery Order
The Defense Logistics Agency awarded a $4,172.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562050449 glycopyrrolate 0.2 mg/ml vials. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a one day period from September 5-6, 2023. As the DLA is responsible for procuring pharmaceuticals and medical supplies for the Department of Defense, this order is likely to support treatment needs for military personnel, veterans, or their families. No subcontractors or set aside designations were indicated.
Generated 12/16/23, 11:25 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/5/23 |